Gujarat Themis Biosyn Limited
Related Stocks
About
Gujarat Themis Biosyn Limited engages in the manufacture of pharmaceuticals and medicinal chemicals in India and Japan. The company offers bulk drugs on job work basis in India. Its products include Rifamycin-S, an intermediate for the treatment of tuberculosis, Mycobacterium avium complex, leprosy, and Legionnaires' disease; Rifamycin-O for the treatment of traveler's diarrhea, irritable bowel syndrome, and hepatic encephalopathy; and Lovastatin. The company was incorporated in 1981 and is based in Mumbai, India.
Price Range
52 Week
Low
225.05
High
479.00
Intraday
Low
349.00
High
377.00
Company's profit divided by outstanding shares.
Ratio of share price to its earnings per share.
Total number of outstanding shares.
Gap between today's open and yesterday's close.
Average daily traded volume.
Highest price reached in the last 30 days.
Lowest price reached in the last 30 days.
Highest price reached in the last six months.
Lowest price reached in the last six months.
Highest price reached in the last year.
Lowest price reached in the last year.
Peer Comparison
| # | Name | Price | Chg % | P/E | EPS | Mkt Cap (Cr) | 52W High | 52W Low |
|---|---|---|---|---|---|---|---|---|
| 1 | Gujarat Themis Biosyn Limited | 374.70 | +6.68% | 83.83 | 4.47 | 4,076 | 479.00 | 225.05 |
| 2 | Aarti Drugs Limited | 413.00 | +0.55% | 19.73 | 20.93 | 3,769 | 534.55 | 318.95 |
| 3 | Aarti Pharmalabs Limited | 874.50 | +1.46% | 37.21 | 23.50 | 7,930 | 946.10 | 585.00 |
| 4 | Abbott India Limited | 26,550.00 | -1.43% | 34.90 | 759.88 | 56,353 | 33,495.00 | 25,150.00 |
| 5 | ANLON HEALTHCARE LIMITED | 14.53 | +0.14% | 21.33 | 0.68 | 772 | 17.27 | 9.08 |
| 6 | Ajanta Pharma Limited | 3,710.00 | -0.22% | 40.84 | 90.83 | 46,276 | 3,796.00 | 2,329.90 |
| 7 | AKUMS DRUGS AND PHARMA L | 744.20 | +0.17% | 39.12 | 19.05 | 11,466 | 775.00 | 409.30 |
| 8 | Alivus Life Sciences Limited | 1,400.00 | +0.41% | 28.55 | 49.03 | 17,188 | 1,418.00 | 819.00 |
| 9 | Alkem Laboratories Limited | 5,475.00 | +1.88% | 30.34 | 180.45 | 65,462 | 5,933.50 | 5,075.00 |
| 10 | Amrutanjan Health Care Limited | 488.00 | -0.78% | 26.16 | 18.67 | 1,409 | 790.95 | 482.80 |
| 11 | Alembic Pharmaceuticals Limited | 826.40 | +0.49% | 23.44 | 35.27 | 16,246 | 1,002.00 | 635.80 |
| 12 | AstraZeneca Pharma India Limited | 7,648.00 | -0.26% | 112.32 | 67.85 | 19,063 | 9,849.50 | 7,551.50 |
| 13 | Aurobindo Pharma Limited | 1,636.20 | +0.55% | 25.56 | 64.00 | 95,360 | 1,682.40 | 1,016.10 |
| Median: 13 Co. | 874.50 | 0.41% | 30.34 | 35.27 | 16,246 | 1,002.00 | 635.80 |